Ramachandran Niro Ph.D 4
4 · Akoya Biosciences, Inc. · Filed Mar 25, 2024
Insider Transaction Report
Form 4
Ramachandran Niro Ph.D
Chief Business Officer
Transactions
- Tax Payment
Common Stock
2024-03-23$4.79/sh−2,006$9,609→ 207,924 total
Footnotes (1)
- [F1]Represents shares withheld to cover taxes on a restricted stock unit award previously granted March 23, 2022, which vests in four (4) annual equal installments beginning on March 23, 2023 and annually thereafter until fully vested.